Back to tickers

Atara Biotherapeutics, Inc. (ATRA)

Nasdaq · CIK 0001604464

Form Report Date Filing Date Description
10-Q 2026-06-30 2026-08-12 10-Q
8-K 2026-08-12 2026-08-12 8-K
8-K 2026-06-22 2026-06-26 8-K
8-K 2026-06-09 2026-06-12 CURRENT REPORT
10-Q 2026-03-31 2026-05-12 10-Q
8-K 2026-05-12 2026-05-12 8-K
8-K 2026-05-07 2026-05-07 8-K
8-K 2026-04-30 2026-05-01 8-K
10-K 2025-12-31 2026-03-16 10-K
8-K 2026-03-16 2026-03-16 8-K
8-K 2026-03-12 2026-03-12 8-K
8-K 2026-03-03 2026-03-03 8-K
8-K 2026-02-20 2026-02-23 8-K
8-K 2026-01-12 2026-01-12 8-K
8-K 2025-12-30 2026-01-02 8-K
10-Q 2025-09-30 2025-11-12 10-Q
8-K 2025-11-12 2025-11-12 8-K
8-K 2025-10-06 2025-10-07 8-K
8-K 2025-09-02 2025-09-04 8-K
10-Q 2025-06-30 2025-08-11 10-Q
8-K 2025-08-11 2025-08-11 8-K
8-K 2025-07-14 2025-07-14 8-K
8-K 2025-06-10 2025-06-11 8-K
8-K 2025-05-14 2025-05-16 8-K
10-Q 2025-03-31 2025-05-15 10-Q
8-K 2025-05-14 2025-05-15 8-K
8-K 2025-05-12 2025-05-12 8-K
8-K 2025-05-05 2025-05-06 8-K
8-K 2025-03-31 2025-04-04 8-K
8-K 2025-03-25 2025-03-31 8-K
10-K 2024-12-31 2025-03-07 10-K
8-K 2025-03-07 2025-03-07 8-K
8-K 2025-03-03 2025-03-03 8-K
8-K 2025-01-27 2025-01-27 8-K
8-K 2025-01-21 2025-01-21 8-K
8-K 2025-01-16 2025-01-16 8-K
8-K 2024-12-20 2024-12-23 8-K
10-Q 2024-09-30 2024-11-12 10-Q
8-K 2024-11-08 2024-11-12 8-K
8-K 2024-10-14 2024-10-15 8-K
8-K 2024-09-03 2024-09-03 8-K
10-Q 2024-06-30 2024-08-12 10-Q
8-K 2024-08-10 2024-08-12 8-K
8-K 2024-07-17 2024-07-17 8-K
8-K 2024-06-20 2024-06-20 8-K
8-K 2024-06-17 2024-06-17 8-K
8-K 2024-06-10 2024-06-11 8-K
10-Q 2024-03-31 2024-05-09 10-Q
8-K 2024-05-09 2024-05-09 8-K
8-K 2024-03-26 2024-03-29 8-K
10-K 2023-12-31 2024-03-28 10-K
8-K 2024-03-28 2024-03-28 8-K
8-K 2024-02-22 2024-02-23 8-K
8-K 2024-01-08 2024-01-09 8-K
8-K 2024-01-08 2024-01-08 8-K
8-K 2023-12-20 2023-12-20 8-K
8-K 2023-11-08 2023-11-09 8-K
8-K 2023-11-01 2023-11-01 8-K
10-Q 2023-09-30 2023-11-01 10-Q
8-K 2023-10-31 2023-11-01 8-K
8-K 2023-09-19 2023-09-20 8-K
10-Q 2023-06-30 2023-08-08 10-Q
8-K 2023-08-08 2023-08-08 8-K
8-K 2023-06-09 2023-06-09 8-K
8-K 2023-05-31 2023-06-05 8-K
8-K 2023-05-12 2023-05-12 8-K
10-Q 2023-03-31 2023-05-08 10-Q
8-K 2023-05-05 2023-05-08 8-K
8-K 2023-03-31 2023-03-31 8-K
8-K 2023-03-10 2023-03-10 8-K
10-K 2022-12-31 2023-02-08 10-K
8-K 2023-02-03 2023-02-08 8-K
8-K 2022-12-30 2023-01-06 8-K
8-K 2022-12-20 2022-12-20 8-K
8-K 2022-12-16 2022-12-19 8-K
10-Q 2022-09-30 2022-11-08 10-Q
8-K 2022-11-08 2022-11-08 8-K
8-K 2022-09-28 2022-09-28 8-K
8-K 2022-09-26 2022-09-27 8-K
10-Q 2022-06-30 2022-08-08 10-Q
8-K 2022-08-02 2022-08-08 8-K
8-K 2022-06-23 2022-06-24 8-K
8-K 2022-05-13 2022-05-19 8-K
10-Q 2022-03-31 2022-05-05 10-Q
8-K 2022-05-05 2022-05-05 8-K
8-K 2022-04-04 2022-04-04 8-K
10-K 2021-12-31 2022-02-28 10-K
8-K 2022-02-28 2022-02-28 8-K
8-K 2022-02-18 2022-02-18 8-K
8-K 2022-01-26 2022-01-26 8-K
8-K 2022-01-10 2022-01-10 8-K
8-K 2021-11-26 2021-11-26 8-K
10-Q 2021-09-30 2021-11-04 10-Q
8-K 2021-11-04 2021-11-04 8-K
8-K 2021-10-02 2021-10-04 8-K
8-K 2021-08-09 2021-08-10 8-K
10-Q 2021-06-30 2021-08-09 10-Q
8-K 2021-08-09 2021-08-09 8-K
8-K 2021-06-08 2021-06-09 8-K
10-Q 2021-03-31 2021-05-04 10-Q
8-K 2021-05-04 2021-05-04 8-K
10-K 2020-12-31 2021-03-01 10-K
8-K 2021-03-01 2021-03-01 8-K
8-K 2021-01-11 2021-01-11 8-K
8-K 2021-01-04 2021-01-04 8-K
8-K 2020-12-08 2020-12-09 8-K
8-K 2020-12-04 2020-12-07 8-K
10-Q 2020-09-30 2020-11-09 10-Q
8-K 2020-11-09 2020-11-09 8-K
10-Q 2020-06-30 2020-08-05 10-Q
8-K 2020-08-05 2020-08-05 8-K
8-K 2020-06-16 2020-06-19 8-K
8-K 2020-05-26 2020-05-28 8-K
8-K 2020-05-08 2020-05-12 8-K
10-Q 2020-03-31 2020-05-06 10-Q
8-K 2020-05-06 2020-05-06 8-K
8-K 2020-04-29 2020-04-30 8-K
10-K 2019-12-31 2020-02-27 10-K
8-K 2020-02-27 2020-02-27 8-K
10-Q 2019-09-30 2019-11-07 10-Q
8-K 2019-11-07 2019-11-07 8-K
8-K 2019-10-21 2019-10-25 8-K
10-Q 2019-06-30 2019-08-08 10-Q
8-K 2019-08-08 2019-08-08 8-K
8-K 2019-07-18 2019-07-22 8-K
8-K 2019-06-27 2019-06-28 8-K
8-K 2019-06-05 2019-06-05 8-K
8-K 2019-05-23 2019-05-28 8-K
10-Q 2019-03-31 2019-05-09 10-Q
8-K 2019-05-09 2019-05-09 8-K
8-K 2019-03-29 2019-04-03 8-K
10-K 2018-12-31 2019-02-26 10-K
8-K 2019-02-26 2019-02-26 8-K
8-K 2019-01-02 2019-01-03 8-K
10-Q 2018-09-30 2018-11-06 10-Q
8-K 2018-11-06 2018-11-06 8-K
8-K 2018-09-11 2018-09-12 8-K
10-Q 2018-06-30 2018-08-01 10-Q
8-K 2018-08-01 2018-08-01 8-K
8-K 2018-06-14 2018-06-18 8-K
8-K 2018-06-07 2018-06-07 8-K
10-Q 2018-03-31 2018-05-08 10-Q
8-K 2018-05-08 2018-05-08 8-K - Q1 2018 EARNINGS RELEASE
8-K 2018-02-28 2018-03-02 8-K
10-K 2017-12-31 2018-02-27 10-K
8-K 2018-02-27 2018-02-27 8-K
8-K 2018-02-21 2018-02-21 8-K
8-K 2018-02-06 2018-02-08 FORM 8-K
8-K 2018-01-03 2018-01-04 8-K
8-K 2017-12-29 2017-12-29 8-K
10-Q 2017-09-30 2017-11-09 10-Q
8-K 2017-11-09 2017-11-09 8-K Q3 EARNINGS RELEASE
10-Q 2017-06-30 2017-08-07 10-Q
8-K 2017-08-07 2017-08-07 8-K - Q2 2017
8-K 2017-06-08 2017-06-08 8K - 2017 ANNUAL MEETING RESULTS
10-Q 2017-03-31 2017-05-04 10-Q
8-K 2017-05-04 2017-05-04 8-K Q1 2017 EARNINGS RELEASE
8-K 2017-04-20 2017-04-20 8-K
8-K 2017-03-27 2017-03-27 8-K
10-K 2016-12-31 2017-03-09 10-K
8-K 2017-03-09 2017-03-09 8-K FYE 2016
8-K 2017-02-06 2017-02-10 FORM 8-K
8-K 2017-02-06 2017-02-07 8-K
10-Q 2016-09-30 2016-11-04 10-Q
8-K 2016-11-04 2016-11-04 8-K
8-K 2016-09-22 2016-09-23 8-K
10-Q 2016-06-30 2016-08-08 10-Q
8-K 2016-08-08 2016-08-08 EARNING RELEASE Q2 2016
8-K 2016-06-23 2016-06-24 8-K
10-Q 2016-03-31 2016-05-06 10-Q
8-K 2016-05-05 2016-05-05 8-K
10-K 2015-12-31 2016-03-04 10-K
8-K 2016-03-03 2016-03-03 8-K
8-K 2016-02-09 2016-02-16 8-K
8-K 2015-12-14 2015-12-14 8-K
8-K 2015-12-09 2015-12-11 8-K
8-K 2015-11-23 2015-11-27 8-K
10-Q 2015-09-30 2015-11-06 10-Q
8-K 2015-11-05 2015-11-05 8-K
8-K 2015-10-12 2015-10-16 8-K
8-K 2015-09-18 2015-09-21 8-K
8-K 2015-09-09 2015-09-14 8-K
10-Q 2015-06-30 2015-08-07 10-Q
8-K 2015-08-06 2015-08-06 8-K